Suchergebnisse - "Mauro, Francesca R"

PubPharm (89)

1

Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines

enthalten in: Blood reviews | 2024

von Mikulska, M. | Oltolini, C. | Zappulo, E. | +5

2

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia : A study by ERIC, the European research initiative on CLL

enthalten in: American journal of hematology | 2023

von Visentin, A. | Chatzikonstantinou, T. | Scarfò, L. | +98

3

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile : results of the GIMEMA phase II LLC1518 - VERITAS study

enthalten in: Haematologica | 2023

von Mauro, F. | Starza, I. | Messina, M. | +44

CommentIn: Haematologica. 2023 Aug 01;108(8):1975-1978. - PMID 36815386

4

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL : Two-Year Follow-Up of a Multicenter Study

enthalten in: Cancers | 2023

von Mauro, F. | Giannarelli, D. | Galluzzo, C. | +21

5

Pre-exposure prophylaxis with tixagevimab/cilgavimab in patients with chronic lymphocytic leukaemia treated with targeted agents

enthalten in: British journal of haematology | 2023

von Mauro, F. | Visentin, A. | Giannarelli, D. | +11

6

The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia : A study by ERIC, the European research initiative on CLL

enthalten in: American Journal of Hematology | 2023

von Visentin, A. | Chatzikonstantinou, T. | Scarfò, L. | +118

7

Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy

enthalten in: British journal of haematology | 2022

von Voso, M. | Pandzic, T. | Falconi, G. | +21

8

COVID-19 severity and mortality in patients with CLL : an update of the international ERIC and Campus CLL study

enthalten in: Leukemia | 2021

von Chatzikonstantinou, T. | Kapetanakis, A. | Scarfò, L. | +98

CommentIn: Leukemia. 2022 Feb;36(2):562-565. - PMID 34937858

9

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group

enthalten in: Hematological oncology | 2021

von Rigolin, G. | Cavazzini, F. | Piciocchi, A. | +27

10

Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia : a multicenter international study

enthalten in: Haematologica | 2021

von Fattizzo, B. | Michel, M. | Zaninoni, A. | +11

1
2
3
4
5
6
7
8
9
Nächster »
[9]